NGM

NGM Biopharmaceuticals, Inc. Common Stock
NGM

Overview Fund Activity
Delisted

NGM was delisted on the 4th of April, 2024.

Back to rankings

128 hedge funds and large institutions have $690M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 53 increasing their positions, 29 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
128
Holders Change
+5
Holders Change %
+4.07%
% of All Funds
2.21%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.09%
New
23
Increased
53
Reduced
29
Closed
17
Calls
$7.99M
Puts
$1.35M
Net Calls
+$6.64M
Net Calls Change
+$4.57M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$56.6M
2
APM
2
Avidity Partners Management
Texas
$23.5M
3
LGM
3
Logos Global Management
California
$11.1M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$51M
5
GPP
5
Great Point Partners
Connecticut
$4.14M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$4.75M
2
Millennium Management
2
Millennium Management
New York
$3.02M
3
FLAM
3
First Light Asset Management
Minnesota
$12.5M
4
PGH
4
Partners Group Holding
Switzerland
$0
5
WP
5
Woodline Partners
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
GPP
26
Great Point Partners
Connecticut
$4.14M +$4.14M +316,256 New
Charles Schwab
27
Charles Schwab
California
$4.12M +$37.7K +2,884 +0.9%
Citadel Advisors
28
Citadel Advisors
Florida
$3.85M +$869K +66,414 +29%
Two Sigma Advisers
29
Two Sigma Advisers
New York
$3.75M +$1.17M +89,700 +46%
CS
30
Candriam SCA
Luxembourg
$3.72M +$875K +66,863 +31%
Renaissance Technologies
31
Renaissance Technologies
New York
$3.59M -$839K -64,168 -19%
Deutsche Bank
32
Deutsche Bank
Germany
$3.44M -$13.9K -1,061 -0.4%
Two Sigma Investments
33
Two Sigma Investments
New York
$3.4M +$1.19M +91,020 +54%
Millennium Management
34
Millennium Management
New York
$3.02M -$2.75M -210,629 -48%
SAM
35
Silvercrest Asset Management
New York
$2.3M -$62.8K -4,797 -3%
HWAM
36
Hennion & Walsh Asset Management
New Jersey
$2.29M +$76.5K +5,846 +3%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$1.97M +$259K +19,840 +15%
PAM
38
Panagora Asset Management
Massachusetts
$1.89M +$636K +48,639 +51%
D.E. Shaw & Co
39
D.E. Shaw & Co
New York
$1.82M -$283K -21,608 -13%
PVI
40
Pura Vida Investments
New York
$1.78M +$1.78M +135,696 New
Lord, Abbett & Co
41
Lord, Abbett & Co
New Jersey
$1.73M – – –
Jennison Associates
42
Jennison Associates
New York
$1.6M +$1.6M +122,430 New
Connor, Clark & Lunn Investment Management (CC&L)
43
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.45M +$976K +74,646 +207%
RJA
44
Raymond James & Associates
Florida
$1.25M +$323K +24,690 +35%
SCM
45
Silverarc Capital Management
Massachusetts
$1.24M +$81.3K +6,214 +7%
RJFSA
46
Raymond James Financial Services Advisors
Florida
$1.11M +$290K +22,199 +35%
AG
47
Algert Global
California
$1.02M +$76.9K +5,877 +8%
CSS
48
Cubist Systematic Strategies
Connecticut
$981K -$1.4M -106,988 -59%
DCM
49
DAFNA Capital Management
California
$980K -$428K -32,700 -30%
SSA
50
Schonfeld Strategic Advisors
New York
$946K +$946K +72,382 New
1
2
3 4 5